What is the Divi's Labs PE ratio today?
Divi's Labs' PE ratio is 87.6 at the 29 October 2026 close (₹9,664.00 a share): a market capitalisation of ₹2,56,096 crore divided by consolidated net profit of ₹2,925 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹2,568 crore) it is 99.7.
What is the Divi's Labs net worth?
Divi's Labs' net worth — shareholders' equity in its consolidated balance sheet — was ₹16,761 crore on 31 March 2026, up 12.0% from ₹14,969 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹2,56,096 crore at the 29 October 2026 close.
What is the Divi's Labs book value per share?
Divi's Labs' book value per share was ₹632.49 on 31 March 2026: shareholders' equity of ₹16,761 crore divided by the 26.5 crore shares in issue, up 12.0% from ₹564.87 a year earlier. The share price at the 29 October 2026 close was ₹9,664.00.
What is the Divi's Labs PB ratio (price to book value)?
Divi's Labs' price-to-book (PB) ratio is 15.28 at the 29 October 2026 close: a market capitalisation of ₹2,56,096 crore divided by shareholders' equity (book value) of ₹16,761 crore on 31 March 2026. That is a book value of ₹632.49 per share against a share price of ₹9,664.00.
What is the Divi's Labs ROE and ROCE?
In FY26, Divi's Labs' return on equity (ROE) was 16.2% and its return on capital employed (ROCE) was 17.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 15.4% and ROCE 17.3%.
What is the Divi's Labs dividend yield?
Divi's Labs' dividend yield is 0.31% at the 29 October 2026 close: dividends of ₹30 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹9,664.00. They were ₹30 on 24 July 2026.
What is the Divi's Labs market cap?
Divi's Labs' market capitalisation was ₹2,56,096 crore (₹2.56 lakh crore) at the 29 October 2026 close: 26.5 crore shares at ₹9,664.00 each.
Is Divi's Labs debt free?
Yes. Divi's Labs had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹3,414 crore of cash, bank balances and current investments.
What is the Divi's Labs debt to equity ratio?
Divi's Labs' debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹16,761 crore. A year earlier, on 31 March 2025, it was 0.00.
What is the Divi's Labs EPS?
Divi's Labs' basic earnings per share (EPS) were ₹96.75 in FY26, against ₹82.53 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹110.21.
What is the Divi's Labs dividend in 2026 and its record date?
In 2026, Divi's Labs has declared one dividend: ₹30 with record date 24 July 2026.
When are the Divi's Labs next results?
Divi's Labs will announce its Q2 FY27 results (July–September 2026) on Saturday, 7 November 2026, the date of the board meeting it has notified to the exchanges.
What is the Divi's Labs promoter holding?
Promoters held 51.88% of Divi's Labs on 30 September 2026, unchanged from the previous quarter and down 0.01 percentage points from 51.89% a year earlier, according to the shareholding pattern filed with NSE.
What is the Divi's Labs free cash flow?
In FY26, Divi's Labs generated ₹2,738 crore of cash from operations and spent ₹2,520 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹218 crore. In FY25 it was ₹215 crore.
What are the Divi's Labs latest quarterly results?
Divi's Labs' latest results are for Q1 FY27 (April–June 2026), filed on 1 August 2026: consolidated net profit ₹902 crore, up 65.5% from ₹545 crore in Q1 FY26; revenue from operations ₹3,080 crore, up 27.8% year on year.
What is the Divi's Labs shareholding pattern?
On 30 September 2026, Divi's Labs' shares were held by promoters 51.88%, foreign portfolio investors (FII/FPI) 20.38%, domestic institutions (DII) 19.17% (including mutual funds at 14.66%) and retail and other non-institutional investors 8.58%. Over the year, FII holding was up 0.99 percentage points from 19.39% and DII holding was down 0.59 percentage points from 19.76%.
What is the Divi's Labs revenue and profit in FY26?
In FY26 (April 2025–March 2026), Divi's Labs' consolidated net profit was ₹2,568 crore, up 17.2% from ₹2,191 crore in FY25, on revenue from operations of ₹10,560 crore (up 12.8%). Over three years, from FY23, net profit was up 40.8%.
How does the Divi's Labs PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit, Divi's Labs' PE ratio is 99.7, the third highest of the four: Laurus Labs 136.4, Cohance Lifesciences 102.8 and Gland Pharma 49.4, a peer average of 96.2. Each is the company's market capitalisation at that price divided by its FY26 net profit.
How does Divi's Labs compare with its peers?
On FY26 consolidated figures, against Laurus Labs, Cohance Lifesciences and Gland Pharma: Divi's Labs' operating margin of 28.2% is the highest of the four (Laurus Labs 19.1%, Cohance Lifesciences 10.6%, Gland Pharma 18.8%; peer average 16.1%); its return on equity of 16.2% is the second highest of the four (Laurus Labs 18.2%, Cohance Lifesciences 6.4%, Gland Pharma 10.5%; peer average 11.7%); its revenue growth over three years of 10.8% a year is the third highest of the four (Laurus Labs 4.1% a year, Cohance Lifesciences 19.2% a year, Gland Pharma 21.1% a year; peer average 14.8% a year).
Divi's Labs vs Laurus Labs: how do they compare?
In FY26, Divi's Labs earned net profit of ₹2,568 crore on revenue of ₹10,560 crore, against ₹889 crore on ₹6,813 crore for Laurus Labs. Divi's Labs' operating margin was 28.2% (Laurus Labs 19.1%) and its return on equity 16.2% (Laurus Labs 18.2%). At the 29 October 2026 close, Divi's Labs' market capitalisation was ₹2,56,096 crore against ₹1,21,243 crore for Laurus Labs, and its PE ratio on FY26 profit 99.7 against 136.4.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
